We focus on helping to improve breast cancer survival rates by detecting cancers earlier so that treatment can be more effective and less invasive.
With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara™ provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us
NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU
1. FDA Clearance applies to 2D. 3D under consideration
2. Published data held on file
Begin patient treatment earlier to improve survival rates
With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs
Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis
Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.
Client undergoes mammogram
Transpara analyses mammogram scan
Radiologist reads with support from Transpara, increasing confidence in decision
Make more accurate and consistent decision
Not all breast AI is the same, please visit us at the ScreenPoint Medical stand #112, X1 in Vienna to
Read more
LONDON (PRWEB) JANUARY 03, 2020 ScreenPoint Medical’s Scientists who developed the Transpara AI decision support system which helps radiologists to identify
Read more
Nico Karssemeijer, CEO and co-founder of ScreenPoint Medical has appeared on Dutch TV (RTL4) describing how breast AI works, developments
Read more
The most advanced version of Transpara™ from ScreenPoint Medical unleashes the power from 2D into 3D mammography: Performance is better,
Read more
ScreenPoint Medical launches its new medical education program with a series of workshops entitled, “The Transpara experience – true multi-vendor,
Read more
WELLINGTON, New Zealand, July 23, 2019 /PRNewswire/ — Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products
Read more
